These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28346227)
1. Reducing expression of synapse-restricting protein Ephexin5 ameliorates Alzheimer's-like impairment in mice. Sell GL; Schaffer TB; Margolis SS J Clin Invest; 2017 May; 127(5):1646-1650. PubMed ID: 28346227 [TBL] [Abstract][Full Text] [Related]
2. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease. Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400 [TBL] [Abstract][Full Text] [Related]
3. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models. Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876 [TBL] [Abstract][Full Text] [Related]
4. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits. Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416 [TBL] [Abstract][Full Text] [Related]
5. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Palop JJ; Chin J; Roberson ED; Wang J; Thwin MT; Bien-Ly N; Yoo J; Ho KO; Yu GQ; Kreitzer A; Finkbeiner S; Noebels JL; Mucke L Neuron; 2007 Sep; 55(5):697-711. PubMed ID: 17785178 [TBL] [Abstract][Full Text] [Related]
6. Enhanced hippocampal TIAM2S expression alleviates cognitive deficits in Alzheimer's disease model mice. Sung KC; Wang LY; Wang CC; Chu CH; Sun HS; Hsiao YH Pharmacol Rep; 2024 Oct; 76(5):1032-1043. PubMed ID: 39012419 [TBL] [Abstract][Full Text] [Related]
7. Drebrin in Alzheimer's Disease. Ishizuka Y; Hanamura K Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022 [TBL] [Abstract][Full Text] [Related]
8. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925 [TBL] [Abstract][Full Text] [Related]
9. A role for β2* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus. Lombardo S; Catteau J; Besson M; Maskos U Neurobiol Aging; 2016 Oct; 46():221-34. PubMed ID: 27522251 [TBL] [Abstract][Full Text] [Related]
10. Interaction of human IAPP and Aβ Chen HC; Cao JX; Cai YT; Du HL; Xi XX; Sun J; Yin J; Gao LP; Jing YH Exp Neurol; 2020 Dec; 334():113490. PubMed ID: 33007295 [TBL] [Abstract][Full Text] [Related]
11. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Palop JJ; Jones B; Kekonius L; Chin J; Yu GQ; Raber J; Masliah E; Mucke L Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9572-7. PubMed ID: 12881482 [TBL] [Abstract][Full Text] [Related]
12. Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease. Su Y; Ni B J Neurosci Res; 1998 Jul; 53(2):177-86. PubMed ID: 9671974 [TBL] [Abstract][Full Text] [Related]
13. Reversal of long-term dendritic spine alterations in Alzheimer disease models. Smith DL; Pozueta J; Gong B; Arancio O; Shelanski M Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16877-82. PubMed ID: 19805389 [TBL] [Abstract][Full Text] [Related]
14. Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease. Melnikova T; Park D; Becker L; Lee D; Cho E; Sayyida N; Tian J; Bandeen-Roche K; Borchelt DR; Savonenko AV Neurobiol Dis; 2016 Dec; 96():171-185. PubMed ID: 27569580 [TBL] [Abstract][Full Text] [Related]
15. Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. Meilandt WJ; Yu GQ; Chin J; Roberson ED; Palop JJ; Wu T; Scearce-Levie K; Mucke L J Neurosci; 2008 May; 28(19):5007-17. PubMed ID: 18463254 [TBL] [Abstract][Full Text] [Related]
16. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease. Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995 [TBL] [Abstract][Full Text] [Related]
17. Storm before the quiet: neuronal hyperactivity and Aβ in the presymptomatic stages of Alzheimer's disease. Stargardt A; Swaab DF; Bossers K Neurobiol Aging; 2015 Jan; 36(1):1-11. PubMed ID: 25444609 [TBL] [Abstract][Full Text] [Related]
18. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease. Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976 [TBL] [Abstract][Full Text] [Related]
19. Reduction of Tet2 exacerbates early stage Alzheimer's pathology and cognitive impairments in 2×Tg-AD mice. Li L; Qiu Y; Miao M; Liu Z; Li W; Zhu Y; Wang Q Hum Mol Genet; 2020 Jul; 29(11):1833-1852. PubMed ID: 31943063 [TBL] [Abstract][Full Text] [Related]
20. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers. Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]